Bulletin
Investor Alert

Vir Biotechnology Inc.

NAS: VIR

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Apr 16, 2021, 7:59 p.m.

VIR
/zigman2/quotes/214486077/composite

$

46.35

Change

-0.03 -0.06%

Volume

Volume 21,346

Quotes are delayed by 20 min

/zigman2/quotes/214486077/composite

Previous close

$ 45.04

$ 46.38

Change

+1.34 +2.98%

Day low

Day high

$43.60

$46.64

Open

52 week low

52 week high

$25.31

$141.01

Open

Insider Actions for Vir Biotechnology Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/13/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Disposition at $43.57 per share. 242,249
04/13/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Derivative/Non-derivative trans. at $1.53 per share. 8,506
04/09/2021 Herbert W. Virgin
EVP, Research & CSO
14,000   Derivative/Non-derivative trans. at $1.53 per share. 21,420
04/08/2021 ARCH Venture Partners LLC
5,989   0
04/08/2021 ARCH Venture Partners LLC
1,019   0
04/08/2021 ARCH Venture Partners LLC
3,161   0
04/08/2021 ARCH Venture Partners LLC
282,219   0
04/08/2021 ARCH Venture Partners LLC
217,781   0
04/08/2021 ARCH Venture Partners LLC
282,219   0
04/08/2021 ARCH Venture Partners LLC
217,781   0
04/07/2021 ARCH Venture Partners LLC
5,989   0
04/07/2021 ARCH Venture Partners LLC
1,019   0
04/07/2021 ARCH Venture Partners LLC
3,161   0
04/07/2021 ARCH Venture Partners LLC
282,219   0
04/07/2021 ARCH Venture Partners LLC
217,781   0
04/07/2021 ARCH Venture Partners LLC
282,219   0
04/07/2021 ARCH Venture Partners LLC
217,781   0
04/01/2021 Jay Parrish
Chief Business Officer
6,944   Disposition at $51.4 per share. 356,921
04/01/2021 Jay Parrish
Chief Business Officer
2,315   Derivative/Non-derivative trans. at $1.58 per share. 3,657
04/01/2021 Jay Parrish
Chief Business Officer
4,629   Derivative/Non-derivative trans. at $1.48 per share. 6,850
03/29/2021 Ann M Hanly
Chief Technology Officer
30,000   Award at $0 per share. 0
03/23/2021 Herbert W. Virgin
EVP, Research & CSO
7,900   Disposition at $53.6 per share. 423,440
03/23/2021 Herbert W. Virgin
EVP, Research & CSO
7,900   Derivative/Non-derivative trans. at $1.53 per share. 12,087
03/10/2021 Herbert W. Virgin
EVP, Research & CSO
2,340   Disposition at $48 per share. 112,320
03/10/2021 Herbert W. Virgin
EVP, Research & CSO
2,340   Derivative/Non-derivative trans. at $1.53 per share. 3,580
03/09/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Disposition at $44.8 per share. 249,088
03/09/2021 Herbert W. Virgin
EVP, Research & CSO
5,560   Derivative/Non-derivative trans. at $1.53 per share. 8,506
03/01/2021 Jay Parrish
Chief Business Officer
6,944   Disposition at $63.44 per share. 440,527
03/01/2021 Jay Parrish
Chief Business Officer
2,314   Derivative/Non-derivative trans. at $1.58 per share. 3,656
03/01/2021 Jay Parrish
Chief Business Officer
4,630   Derivative/Non-derivative trans. at $1.48 per share. 6,852

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
28 Purchases
18 Sales
402,630
2,089,292
Last 6 months
49 Purchases
34 Sales
626,324
2,375,986
Last 12 months
92 Purchases
89 Sales
1,124,462
2,954,882

Officers and Executives

Dr. George A. Scangos
President, Chief Executive Officer & Director
Mr. Howard Horn
CFO, Secretary & Principal Accounting Officer
Dr. Michael E. Kamarck
Chief Technology Officer
Dr. Phil Pang
Chief Medical Officer
Dr. Herbert W. Virgin
Chief Scientific Officer & Executive VP-Research
Mr. Steven Rice
Chief Administrative Officer
Dr. Jay Parrish
Chief Business Officer
Dr. Antonio Lanzavecchia
Senior Vice President
Dr. Lynne Krummen
SVP-Regulatory Affairs & Program Leadership
Dr. David L. Gollaher
Head-Policy & Government Affairs
Ms. Irene Pleasure
Senior Vice President & General Counsel
Dr. Vicki L. Sato
Non-Executive Chairman
Mr. Dipchand V. Nishar
Independent Director
Ms. Sona Saira Ramasastry
Independent Director
Dr. Charles Elliott Sigal
Independent Director
Ms. Janet Ann Napolitano
Independent Director
Mr. Jeffrey S. Hatfield
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Mr. Robert J. Perez
Independent Director
Dr. Phillip A. Sharp
Independent Director
Mr. Robert J. More
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.